Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Smart Soup is a traditional Chinese medicine (TCM) formula composed of three herbs—Rhizoma Acori Tatarinowii, Poria cum Radix Pini, and Radix Polygalae—in equal parts. It has been used in China for centuries to treat amnesia and cognitive impairment. Modern research has focused on its potential as a multi-target therapy for Alzheimer's disease (AD) and mild cognitive impairment (MCI). Preclinical studies show that Smart Soup reduces amyloid-β levels, amyloidosis, gliosis, and neuronal loss in animal models of AD. Mechanistically, Radix Polygalae appears to reduce amyloid-β generation while Rhizoma Acori Tatarinowii and Poria cum Radix Pini provide neuroprotective effects against amyloid toxicity. Clinical trials are ongoing to evaluate its efficacy in improving cognition and behavior in patients with AD or MCI[1][2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on smart soup.